Utility of HIV-1 EQ SuperLow Viral load Testing in HIV-associated Cognitive Impairment

(Presented at the 2010 III International Clinical Virology Symposium and Advances in Vaccines in Buenos Aires, Argentina) Summary:  This study assessed whether low levels of HIV in cerebrospinal fluid (CSF) were associated with inter-individual differences in ART regimens and neuropsychological (NP) performance using bioMONTR’s HIV-1 SuperLow assay.